Wafer Ann Poll, page-9

First 9 Last

Share
Profile

Follow
Cguv

2,893 Posts.

1113

20/07/21

16:25

Post #: 54635909
Share

Originally posted by jackfrost ↑

very wishy washy announcement the last one with regard to timeline

time consuming is very true

likely we will be in same position in 3-6 months time, still in the dark, and share price is reflecting that now at 14.5

us long term holders are all to familiar with this - has been the same for 4-5 years now

not sure this technology works, lots of non platform and platform lots, but no report on what is really going on

there was one announcement last year about transistors! wtf happened to any further mention of that??

looking less and less likely of eventual success - I know some of you guys will get upset because many of you are so emotionally involved, but it seems like the never ending story

We are getting nowhere with this stock - and don't say I am downramping and trying to get stock cheaper. I have owned this stock for many years, and certainly don't want to buy any more. I am just fed up with the ongoing stalling and lack of anything concrete coming from this company. We have no numbers, no data, and no idea about retention - and don't give me the line about confidentiality and nda - that's a cop out. If they report numbers - so what - it has no bearing on anyone else's ability to copy the tech. They have to disclose the metrics at some point in order to get a sale.

Looking a lot like that company that said they could test for every disease known to man using a magic black box with just a pinprick of a person's blood. That company got some very high profile people to invest good money - and it ended up a scam.

This looks very similar unfortunately

Hope I am wrong, but most of us don't want to be 75 when this company finally does anything of significance, if ever.

Expand

welcome back Jack
At least you posted under your known anonymous moniker
courage to you ....
And each to his own

Oh and the Theranos thing....

Eerily similar.........

4ds market cap US $ 145 Million

THERANOS

Don't Invest More than You can Afford to Lose

4DS Price at posting: 14.5¢ Sentiment: Hold Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

ZNC

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The iron ore comeback: Can it last?

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

HAS

Hastings progressing Yangibana to production with lower costs

There are more pages in this discussion • 17 more messages in this thread...

First 9 Last

Add 4DS (ASX) to my watchlist

(20min delay)
Last 8.4¢		Change -0.004(4.55%)		Mkt cap ! $148.1M

Open	High	Low	Value	Volume
8.9¢	8.9¢	8.1¢	$608.8K	7.017M

Buyers (Bids)

No.	Vol.	Price($)
1	458642	8.4¢

Sellers (Offers)

Price($)	Vol.	No.
8.9¢	125832	2

View Market Depth

No.	Vol.	Price($)
1	458642	0.084
2	512195	0.082
4	122500	0.080
5	437531	0.079
1	38000	0.078

Price($)	Vol.	No.
0.089	125832	2
0.090	538620	4
0.091	408000	2
0.092	359361	3
0.093	100000	1

Last trade - 16.10pm 30/09/2024 (20 minute delay)

4DS (ASX) Chart

Wafer Ann Poll, page-9

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The iron ore comeback: Can it last?

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Hastings progressing Yangibana to production with lower costs

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Wafer Ann Poll, page-9

Top Stories

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The iron ore comeback: Can it last?

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Hastings progressing Yangibana to production with lower costs

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News